Renal cell carcinomas (RCCs) driven by <i>TFE3</i> rearrangement or <i>TFEB</i> alteration (MiT-RCC) account for up to 40% of pediatric RCCs but are rare in adults. Here, TFE3 is linked to renal cell carcinoma.